{"date_last_evaluated":"2016-03-10","review_status":"no assertion provided","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"6728","interpretation":"not provided","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND Neoplasm of stomach","id":"RCV000427078"}
{"date_last_evaluated":"2019-05-28","review_status":"criteria provided, multiple submitters, no conflicts","variation_archive_id":"VCV000003520","version":"2","submission_count":"2","trait_set_id":"6564","interpretation":"Likely benign","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND Neural tube defects, folate-sensitive","id":"RCV000259890"}
{"date_last_evaluated":"2016-07-11","review_status":"reviewed by expert panel","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"26869","interpretation":"drug response","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND cyclophosphamide response - Toxicity/ADR","id":"RCV000211133"}
{"date_last_evaluated":"2016-07-11","review_status":"reviewed by expert panel","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"26870","interpretation":"drug response","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND carboplatin response - Efficacy","id":"RCV000211336"}
{"date_last_evaluated":"2018-05-14","review_status":"reviewed by expert panel","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"35046","interpretation":"drug response","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND methotrexate response - Dosage, Efficacy, Toxicity/ADR","id":"RCV000417131"}
{"date_last_evaluated":"2017-12-30","review_status":"no assertion criteria provided","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"6404","interpretation":"Uncertain significance","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND Venous thrombosis","id":"RCV000761447"}
{"review_status":"no assertion criteria provided","variation_archive_id":"VCV000003520","version":"1","submission_count":"1","trait_set_id":"6607","interpretation":"Uncertain significance","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND Gastrointestinal stromal tumor","id":"RCV000144921"}
{"date_last_evaluated":"2017-01-13","review_status":"criteria provided, multiple submitters, no conflicts","variation_archive_id":"VCV000003520","version":"6","submission_count":"2","trait_set_id":"9460","interpretation":"Uncertain significance, other","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND not provided","id":"RCV000153516"}
{"date_last_evaluated":"2019-06-11","review_status":"no assertion criteria provided","variation_archive_id":"VCV000003520","version":"7","submission_count":"2","trait_set_id":"916","interpretation":"Conflicting interpretations of pathogenicity","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND MTHFR deficiency, thermolabile type","id":"RCV000003697"}
{"date_last_evaluated":"2018-07-13","review_status":"criteria provided, conflicting interpretations","variation_archive_id":"VCV000003520","version":"2","submission_count":"2","trait_set_id":"9590","interpretation":"Conflicting interpretations of pathogenicity","variation_id":"3520","title":"NM_005957.5(MTHFR):c.665C\u003eT (p.Ala222Val) AND not specified","id":"RCV000428048"}
{"date_last_evaluated":"2019-11-25","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","version":"5","submission_count":"1","trait_set_id":"7920","interpretation":"Likely benign","variation_id":"37594","title":"NM_007294.3(BRCA1):c.446A\u003eC (p.Glu149Ala) AND Hereditary breast and ovarian cancer syndrome","id":"RCV000458634"}
{"date_last_evaluated":"2019-12-31","review_status":"criteria provided, conflicting interpretations","variation_archive_id":"VCV000046503","version":"4","submission_count":"3","trait_set_id":"9460","interpretation":"Conflicting interpretations of pathogenicity","variation_id":"46503","title":"NM_033056.4(PCDH15):c.5565C\u003eT (p.Ala1855=) AND not provided","id":"RCV000727222"}
{"date_last_evaluated":"2019-12-31","review_status":"criteria provided, conflicting interpretations","variation_archive_id":"VCV000007884","version":"10","submission_count":"4","trait_set_id":"9460","interpretation":"Conflicting interpretations of pathogenicity","variation_id":"7884","title":"NM_000350.3(ABCA4):c.6148G\u003eC (p.Val2050Leu) AND not provided","id":"RCV000078671"}
{"date_last_evaluated":"2020-01-01","review_status":"criteria provided, multiple submitters, no conflicts","variation_archive_id":"VCV000000822","version":"13","submission_count":"4","trait_set_id":"13598","interpretation":"Pathogenic/Likely pathogenic, risk factor","variation_id":"822","title":"NM_000038.6(APC):c.3920T\u003eA (p.Ile1307Lys) AND Hereditary cancer-predisposing syndrome","id":"RCV000115087"}
{"date_last_evaluated":"2020-01-19","review_status":"criteria provided, multiple submitters, no conflicts","variation_archive_id":"VCV000017674","version":"15","submission_count":"6","trait_set_id":"7920","interpretation":"Pathogenic","variation_id":"17674","title":"NM_007294.3(BRCA1):c.4065_4068del (p.Asn1355fs) AND Hereditary breast and ovarian cancer syndrome","id":"RCV000048431"}
{"date_last_evaluated":"2019-12-30","review_status":"criteria provided, multiple submitters, no conflicts","variation_archive_id":"VCV000042540","version":"11","submission_count":"3","trait_set_id":"17368","interpretation":"Pathogenic","variation_id":"42540","title":"NM_000256.3(MYBPC3):c.1504C\u003eT (p.Arg502Trp) AND Hypertrophic cardiomyopathy","id":"RCV000203913"}
